OPKO Health, Inc.
4.58xPrice / tangible book
Market cap
$1.22B
Tangible equity
$267.39M
Price / tangible book
4.58x
Price / book
0.97x
Return on equity
-17.8%
Return on assets
-11.7%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: OPK stock price at premium vs JPM $1.64 current versus $1.12 implied using P/TBV multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JPM's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Multiple premium
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · JPM FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$1.22B
Tangible equity
$267.39M
Price / tangible book
4.58x
Price / book
0.97x
Return on equity
-17.8%
Return on assets
-11.7%
Efficiency ratio
—
Price / tangible book
Market cap
$953.33B
Tangible equity
$306.21B
Price / tangible book
3.11x
Price / book
2.63x
Return on equity
15.7%
Return on assets
1.3%
Efficiency ratio
109.9%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
JPMORGAN CHASE & CO · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
0.18x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
—
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
—
Total debt
Interest-bearing obligations outstanding
$687.93M
$64.78B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
Bank of America Corporation
OPK vs BAC
Citigroup Inc.
OPK vs C
Wells Fargo & Company
OPK vs WFC
The Goldman Sachs Group, Inc.
OPK vs GS
Morgan Stanley
OPK vs MS
PNC FINANCIAL SERVICES GROUP, INC.
OPK vs PNC
US BANCORP \DE\
OPK vs USB
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.